Chondrocyte therapeutic delivery system
First Claim
Patent Images
1. A method for modifying an environment of a cell associated with a disorder using a genetically altered chondrocyte, comprising:
- providing a genetically altered chondrocyte, wherein the genetically altered chondrocyte has been altered to express a therapeutic agent;
delivering the genetically altered chondrocyte to an atypical chondrocyte environment of a cell associated with a disorder such that the genetically altered chondrocyte does not become a structural component of the atypical chondrocyte environment surrounding the cell; and
expressing the therapeutic agent to a level sufficient to modify the atypical chondrocyte environment surrounding the cell.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and compositions for producing therapeutic agents using chondrocytes are provided. The genetically engineered chondrocytes can be used to express the therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.
99 Citations
8 Claims
-
1. A method for modifying an environment of a cell associated with a disorder using a genetically altered chondrocyte, comprising:
-
providing a genetically altered chondrocyte, wherein the genetically altered chondrocyte has been altered to express a therapeutic agent; delivering the genetically altered chondrocyte to an atypical chondrocyte environment of a cell associated with a disorder such that the genetically altered chondrocyte does not become a structural component of the atypical chondrocyte environment surrounding the cell; and expressing the therapeutic agent to a level sufficient to modify the atypical chondrocyte environment surrounding the cell. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
Specification